$4.61
2.50% today
Nasdaq, Feb 05, 04:19 pm CET
ISIN
US20451W1018
Symbol
CMPS

Compass Pathways Plc - ADR Stock price

$4.73
-0.02 0.42% 1M
-2.15 31.25% 6M
+0.95 25.13% YTD
-6.28 57.04% 1Y
-10.12 68.15% 3Y
-12.27 72.18% 5Y
-12.27 72.18% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.42 9.74%
ISIN
US20451W1018
Symbol
CMPS

Key metrics

Market capitalization $323.63m
Enterprise Value $148.84m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 1.68
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-169.05m
Free Cash Flow (TTM) Free Cash Flow $-105.63m
Cash position $207.34m
EPS (TTM) EPS $-2.20
P/E forward negative
Short interest 5.30%
Show more

Is Compass Pathways Plc - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Compass Pathways Plc - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Compass Pathways Plc - ADR forecast:

11x Buy
100%

Analyst Opinions

11 Analysts have issued a Compass Pathways Plc - ADR forecast:

Buy
100%

Financial data from Compass Pathways Plc - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 0.18 0.18
91% 91%
-
- -
-
-
- Selling and Administrative Expenses 54 54
16% 16%
-
- Research and Development Expense 115 115
43% 43%
-
-170 -170
32% 32%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -169 -169
29% 29%
-
Net Profit -145 -145
24% 24%
-

In millions USD.

Don't miss a Thing! We will send you all news about Compass Pathways Plc - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Compass Pathways Plc - ADR Stock News

Neutral
Business Wire
about 4 hours ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference at 8:40 am ET on February 12th, 2025. A live audio webcast of the presentation wi...
Neutral
Business Wire
15 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today announced the appointment of Steve Levine, M.D., as Chief Patient Officer, effective immediately. In this newly developed executive team role, Dr. Levine will be responsible for ensur...
Neutral
Business Wire
26 days ago
LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase...
More Compass Pathways Plc - ADR News

Company Profile

Head office United Kingdom
CEO Kabir Nath
Employees 186
Founded 2016
Website compasspathways.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today